niraparib 100 mg (Zejula 100 mg)
Generic Name: niraparib
Pill with imprint niraparib 100 mg is Purple / White, Capsule-shape and has been identified as Zejula 100 mg. It is supplied by Tesaro Inc..
Zejula is used in the treatment of peritoneal cancer; ovarian cancer; fallopian tube cancer and belongs to the drug class PARP inhibitors. Zejula 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for niraparib 100 mg
Zejula
- Generic Name:
- niraparib
- Imprint:
- niraparib 100 mg
- Strength:
- 100 mg
- Color:
- Purple / White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- PARP inhibitors
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Tesaro Inc.
- National Drug Code (NDC):
- 69656-0103
More about Zejula (niraparib)
- Zejula Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 7 Reviews
- Drug class: PARP inhibitors
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
